NCT06143410View on ClinicalTrials.gov

Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Diagnostic Gastroscopy
Interventions
DRUG

Lidocaine 2% Injectable Solution

administration of a bolus of lidocaine 1.5 mg/kg

DRUG

Saline administration as placebo

administration of a bolus of saline solution as a placebo

DRUG

Propofol injection

Sedation by total intravenous administration (TIVA) of propofol using target controlled infusion (TCI)

PROCEDURE

gastroscopy

esogastroduodenoscopy

Trial Locations (1)

1070

RECRUITING

Boudart Céline, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER